PD37-06 REAL-WORLD ADOPTION AND IMPACT OF NEOADJUVANT CHEMOTHERAPY ON SURVIVAL OUTCOMES IN BLADDER CANCER: A 20-YEAR FOLLOW-UP MULTI-CENTER STUDY

Mario de Angelis, Francesco Pellegrino, Pietro Scilipoti, Shahrokh F. Shariat, Yasuhisa Fujii, Morgan Rouprêt, Flavia Proietti, Stefania Zamboni, Gerald Bastian Schulz, Guillaume Ploussard, M. Roumiguié, Alessando Antonelli, M.c. Mir, Paolo Umari, Roberto Contieri, Jeremy Yuen‐Chun Teoh, José Daniel Subiela, Renate Pichler, Élisabeth Grobet-Jeandin, Keiichiro Mori, Francesco Del Giudice, Francesco Soria, David D‘Andrea, Ekaterina Laukhtina, Francesco Montorsi, Alberto Briganti, Marco MoschiniThe Journal of Urology 2025 · DOI

BibTeX
@article{angelis2025pd,
  author = {Mario de Angelis and Francesco Pellegrino and Pietro Scilipoti and Shahrokh F. Shariat and Yasuhisa Fujii and Morgan Rouprêt and Flavia Proietti and Stefania Zamboni and Gerald Bastian Schulz and Guillaume Ploussard and M. Roumiguié and Alessando Antonelli and M.C. Mir and Paolo Umari and Roberto Contieri and Jeremy Yuen‐Chun Teoh and José Daniel Subiela and Renate Pichler and Élisabeth Grobet-Jeandin and Keiichiro Mori and Francesco Del Giudice and Francesco Soria and David D‘Andrea and Ekaterina Laukhtina and Francesco Montorsi and Alberto Briganti and Marco Moschini},
  title = {{PD37-06 REAL-WORLD ADOPTION AND IMPACT OF NEOADJUVANT CHEMOTHERAPY ON SURVIVAL OUTCOMES IN BLADDER CANCER: A 20-YEAR FOLLOW-UP MULTI-CENTER STUDY}},
  journal = {The Journal of Urology},
  year = {2025},
  doi = {10.1097/01.ju.0001110188.58981.bc.06},
}

Loading related content...

Figure